Return to study ST002735 main page
MB Sample ID: SA288605
| Local Sample ID: | RS_P12 |
| Subject ID: | SU002841 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Gender: | Male |
Select appropriate tab below to view additional metadata details:
Treatment:
| Treatment ID: | TR002850 |
| Treatment Summary: | Patients with indications of add-on liraglutide were started on treatment by their physician in a scaled-up dose from 0.6 mg to 1.8 mg of a once-daily subcutaneous injection over a period of three weeks. The follow-up visit was scheduled 3 months after receiving the full dose (1.8 mg) of liraglutide. Urine samples were collected at two time points: one sample before and another sample after treatment with liraglutide. Blood samples were collected by venipuncture into plain tubes (Vacutainer, BD Biosciences, San Jose, CA, USA) from each patient after a 10 h fast. The plasma was separated by centrifugation (15 min, 3000× g), divided into several aliquots, and stored at −80 °C for further analysis. |
| Treatment Compound: | Liraglutide |
